Stocklytics Platform
Tandem Diabetes Care
TNDM61
$35.15arrow_drop_down6.28%-$2.35
NASDAQ - As of Jan 20, 8:09 AM EST Market Closed
TNDM61

$35.15

arrow_drop_down6.28%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Tandem Diabetes Care (TNDM) Stocklytics Forecast

Tandem Diabetes Care Inc (TNDM) is an innovative medical device company that specializes in the design, development, and commercialization of advanced insulin delivery systems for people with diabetes. With its cutting-edge technology and commitment to improving the lives of patients, Tandem Diabetes Care is well-positioned for growth in the fast-growing diabetes management market.
The company's flagship product is the Tandem Diabetes Care insulin pump, which offers a convenient and personalized way for patients to manage their insulin delivery. The pump utilizes advanced algorithms and wireless technology to automate insulin dosing, making it easier for patients to maintain stable blood glucose levels. This advanced technology not only improves patient outcomes but also reduces the burden of daily diabetes management.
add Tandem Diabetes Care  to watchlist

Keep an eye on Tandem Diabetes Care

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Tandem Diabetes Care (TNDM) stock?

Analysts have set a target price of $42.33 for Tandem Diabetes Care (TNDM), based on forecasts from 24 analysts. The predicted price range extends from a high of $75 to a low of $21. This represents a potential increase of up to 113.37% and a decrease of -40.26% from the current price of $35.15. These forecasts are as of 2023 May 05.
help

What are the analyst ratings for Tandem Diabetes Care (TNDM) stock?

The analyst ratings for Tandem Diabetes Care (TNDM) are distributed as follows: 15 analysts recommend buying, 6 have a neutral stance, and 1 suggest selling. The prevailing sentiment among the total of 22 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Tandem Diabetes Care .
help

What is the AI price prediction for Tandem Diabetes Care (TNDM) stock?

At present, there is no AI or machine-learning-based price prediction available for Tandem Diabetes Care (TNDM) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level